Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial-Reference-Cited by-同舟云学术

Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial

Published:2021-12 Issue:6 Volume:4 Page:948-954
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Bitting Rhonda L.^ORCID,Healy Patrick^ORCID,George Daniel J.,Anand Monika,Kim Sung^ORCID,Mayer Tina^ORCID,Winters Carol,Riggan Colleen,Rasmussen Julia^ORCID,Wilder Rhonda,Stein Mark^ORCID,Frizzell Bart^ORCID,Harrison Michael R.,Zhang Tian,Lee William R.,Wu Yuan,Koontz Bridget F.,Armstrong Andrew J.

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference26 articles.

1. Early salvage radiotherapy following radical prostatectomy;Pfister;Eur Urol,2014

2. Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy;Trock;JAMA,2008

3. Improved metastasis-free and survival outcomes with early salvage radiotherapy in men with detectable prostate-specific antigen after prostatectomy for prostate cancer;Stish;J Clin Oncol,2016

4. Comparison between adjuvant and early-salvage postprostatectomy radiotherapy for prostate cancer with adverse pathological features;Hwang;JAMA Oncol,2018

5. Timing of radiotherapy after radical prostatectomy: first results from the RADICALS RT randomised controlled trial;Parker;Ann Oncol,2019

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk Stratification of Patients with Recurrence After Primary Treatment for Prostate Cancer: A Systematic Review;European Urology;2024-09

2. Current status and perspectives on the use of androgen receptor pathway inhibitors in the salvage radiotherapy setting;Prostate Cancer and Prostatic Diseases;2024-08-13

3. Intensifying Salvage Therapy in Prostate-specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy with Apalutamide, Salvage Radiation, and Docetaxel: The Phase 2 STARTAR Trial;European Urology Oncology;2024-07

4. Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy - a retrospective multi-institutional propensity score analysis;European Journal of Nuclear Medicine and Molecular Imaging;2024-06-28

5. Combination of Abiraterone Acetate, Prostate Bed Radiotherapy, and Luteinizing Hormone-releasing Hormone Agonists in Biochemically Relapsing Patients After Prostatectomy (CARLHA): A Phase 2 Clinical Trial;European Urology Oncology;2024-05